SlideShare a Scribd company logo
Dr. Laxmi Shrikhande
MD; FICOG; FICMCH;FICMU
 Director-Shrikhande Fertility Clinic, Nagpur
 Senior Vice President FOGSI 2012
 National Corresponding Editor-Journal of OB/GY of India
 Peer Reviewer-The Journal of OB / GY of India
 Publications-Eleven National & seven International
 Presented Papers at FIGO,SAFOG,AOFOG,AICC RCOG
 Editor-FOGSI Focus on SUI
 Received Best committee award of FOGSI
 Received Bharat Excellence award
Multiple pregnancy after
ART
Dr Laxmi Shrikhande
Director-Shrikhande Fertility Clinic,
Nagpur, INDIA
Why so much concern?
• undesirable complication of ovulation induction
and/or ovulation enhancement
• constitute an important health problem due to
high perinatal risks and increased health costs.
Is it different from
natural multiple gestation??
• retrospective analysis
• 106 IVF group and 256 spontaneous twin pregnancies
• The mothers in the IVF group were significantly older than those in the
control group (32±4 years vs 28±4 years, P<0.05).
• The incidence rates of gestational hypertension and gestational
diabetes in the IVF group were significantly higher than in the
control group (P<0.05).
• No significant differences were observed for neonatal physical development,
the incidence of birth defects, and the incidence and mortality of perinatal
diseases (P>0.05).
CONCLUSIONS:
• Twins conceived by IVF have similar outcomes as spontaneously
conceived twins in the perinatal period.
• However, special attention is needed to monitor the levels of blood
pressure and blood glucose for pregnant women with twins conceived by
IVF during prenatal checkups.
Zhongguo Dang Dai Er Ke Za Zhi. 2015
Obstetric and perinatal outcomes of twin pregnancies
conceived following IVF/ICSI compared with
spontaneously conceived twin pregnancies
• retrospective study
• of all viable dichorionic-diamniotic (DCDA) twin pregnancies (n=539)
• The ART conceived group were on average 4 years older (36.8±4.23 vs
32.3±4.93 years) and more frequently nulliparous (73.7%; n=126 vs
36.1%; n=133) than their SC counterparts (p<0.001).
• There was no significant difference in maternal antenatal complications.
• ART twins were twice as likely to be delivered by caesarean
section (CS) (OR 2.35; 95% CI 1.76-3.14).
• There was no significant difference in the rates of preterm birth or
NICU admission according to mode of conception.
• ART conceived twins were almost twice as likely to be delivered
moderately preterm (32-33(+6)) (OR 1.98, 95% CI 1.21-3.23) and
were more likely to have RDS and neonatal hypoglycaemia
CONCLUSIONS:
• However, for those that do conceive twins, they can be advised that
assisted conception conveys no significant disadvantage over
naturally conceived twin pregnancies.
Eur J Obstet Gynecol Reprod Biol. 2014
Features of multiple pregnancies
obtained by in vitro fertilization
• A total of 401 spontaneous multiple pregnancies and 128 IVF multiple
pregnancies were included in the study.
• Rate of multiple pregnancies for live births and IVF rate were 3.8% and
0.79%, respectively.
• The mean maternal age was 30.1 years (21-43) in the IVF group and 27.9
years (13-43) in the spontaneous group (P < 0.05).
• The cesarean delivery rate was 100% in the IVF group and 78% in the
spontaneous group (P = 0.002).
• Premature rupture of membranes rate was 9.8% in the IVF group
and 3.6% in the spontaneous group (P < 0.05).
CONCLUSIONS:
• We found maternal age, premature rupture of membranes and cesarean
delivery rate significantly high in the IVF group.
• No significant differences were found between spontaneous and IVF
multiple pregnancies in terms of demographic features, hospitalization stay
and rate, admission to neonatal intensive care unit, mortality and congenital
malformation.
Pediatr Int. 2014 Oct;56(5):735-41
Prevention is better than cure!!!
• All efforts should be made to assure a singleton
birth when treating infertility.
• Tight rope walk for IVF consultants
• Risk of multiple pregnancy vs the success
rate/cycle
Reprod Biomed Online. 2014
IUI-When to cancel the cycle
How many embryos???
• Elective single embryo transfer (eSET) is
advocated in most European countries.
• In Belgium and Sweden, eSET is mandatory for
couples with a good prognosis.
• However, despite clinical recommendations and
policy statements, patients in clinical practice
frequently do request for the transfer of multiple
embryos in order to have twins.
Ann Med Health Sci Res. 2015 Jan-Feb;5(1)
Elective single versus double embryo transfer:
live birth outcome and patient acceptance
in a prospective randomised trial
• 199 women <38 years of age undergoing their first IVF
treatment in a private centre were included in a
prospective open-label randomised controlled trial.
• Of 98 patients selected for eSET, 40% refused and
preferred eDET even after having been well informed
about its benefits.
Reprod Fertil Dev. 2014
Number of embryos for transfer
following IVF / ICSI
• Multiple embryo transfer during IVF increases multiple pregnancy
rates causing maternal and perinatal morbidity.
• Single embryo transfer is now being seriously considered as a
means of minimising the risk of multiple pregnancy.
• However, this needs to be balanced against the risk of jeopardising
the overall live birth rate.
• Fourteen RCTs were included in the review (2165 women).
Thirteen compared cleavage-stage transfers (2017 women) and two
compared blastocyst transfers (148 women): one study compared
both.
Cochrane Database Syst Rev. 2013
Number of embryos for transfer
following IVF / ICSI
AUTHORS' CONCLUSIONS:
• In a single fresh IVF cycle, single embryo transfer is
associated with a lower live birth rate than double embryo
transfer.
• However, there is no evidence of a significant difference in the
cumulative live birth rate when a single cycle of double embryo
transfer is compared with repeated SET (either two cycles of fresh
SET or one cycle of fresh SET followed by one frozen SET in a
natural or hormone-stimulated cycle).
• Single embryo transfer is associated with much lower rates of
multiple pregnancy than other embryo transfer policies.
• A policy of repeated SET may minimise the risk of multiple
pregnancy in couples undergoing ART without substantially reducing
the likelihood of achieving a live birth.
• Most of the evidence currently available concerns younger women
with a good prognosis.
Cochrane Database Syst Rev. 2013
Clinical effectiveness of elective single versus
double embryo transfer:
meta-analysis from randomised trials
• eight eligible trials (n=1367).
• A total of 683 and 684 women randomised to the single and double
embryo transfer arms, respectively,
• The overall live birth rate in a fresh IVF cycle was lower after single
(181/683, 27%) than double embryo transfer (285/683, 42%)
CONCLUSIONS:
• Elective single embryo transfer results in a higher chance of
delivering a term singleton live birth compared with double embryo
transfer.
• Although this strategy yields a lower pregnancy rate than a
double embryo transfer in a fresh IVF cycle, this difference is almost
completely overcome by an additional frozen single embryo transfer
cycle.
• The multiple pregnancy rate after elective single embryo transfer is
comparable with that observed in spontaneous pregnancies.
BMJ. 2010
ET practices in the United States
• Retrospective cohort analysis
• Of 134,381 ART transfer cycles performed in 2012, 51,262 resulted in live
births, of which 13,563 (26.5%) were multiple births: 13,123 twin and 440
triplet and higher order births.
• Almost half of these multiple births resulted from the following four cycle
types:
– two fresh blastocyst transfers -less than 35 years ,
– two fresh blastocyst transfers among donor-oocyte recipients ,
– two frozen/thawed ETs among patients less than 35 years
– More than half of triplet or higher order births resulted from the transfer
of two embryos among frozen/thawed autologous transfers).
CONCLUSION-
• A substantial reduction of ART-related multiple (both twin and triplet or
higher order) births in the United States could be achieved by single
blastocyst transfers among favorable and average prognosis patients less
than 35 years of age and donor-oocyte recipients.
Fertil Steril. 2015 Apr;103(4):954-61
ASRM guidelines
A. Patients under the age of 35 who have a favorable prognosis should be offered a
single-embryo transfer and no more than two embryos (cleavage stage or
blastocyst) should be transferred . If two embryos are transferred, the patient(s)
must be counseled regarding the risks of multifetal pregnancy and the counseling
should be documented in the patient's permanent medical record.
B. For patients between 35 and 37 years of age who have a favorable prognosis, no
more than two cleavage stage embryos should be transferred. All others in this
age group should have no more than three cleavage stage embryos
transferred. If extended culture is performed, no more than two blastocysts
should be transferred to women in this age group.
C. For patients between 38 and 40 years of age who have a favorable prognosis, no
more than three cleavage stage embryos or two blastocysts should be
transferred. All others in this age group should have no more than four cleavage-
stage embryos or three blastocysts transferred.
D. For patients 41–42 years of age, no more than five cleavage-stage embryos or
three blastocyts should be Transferred.
Fertil Steril. 2013
ASRM guidelines
E. In each of the above age groups, for patients with two or more
previous failed fresh IVF cycles or a less favorable prognosis, one
additional embryo may be transferred according to individual
circumstances.The patient must be counseled regarding the risks of
multifetal pregnancy. Both the counseling and the justification for exceeding
the recommended limits must be documented in the patient(s)'s permanent
medical record.
F. In women >43 years of age, there are insufficient data to recommend a limit
on the number of embryos to transfer.
G. In donor-egg cycles, the age of the donor should be used to determine the
appropriate number of embryos to transfer, but when the donor is <35
years of age single embryo transfer should be strongly considered.
H. In frozen-embryo transfer cycles, the number of good quality thawed
embryos transferred should not exceed the recommended limit on
the number of fresh embryos transferred for each age group.
Fertil Steril. 2013
Beyond the ASRM transfer guidelines:
how many cleavage-stage embryos are safe
to transfer in women ≥43 years old?
• Retrospective cohort.
• A total of 567 cycles in 464 patients aged 43-45 years, whose IVF
cycles were characterized by transfer of five to eight cleavage-stage
embryos were identified
• Live birth rates per transfer were 14.4%, 9.4%, and 1.3% for
women aged 43, 44, and 45 years, respectively. In 43-year-old
women, 2.9% (2/69) of pregnancies were triplet gestations (one
selective reduction and one spontaneous reduction).
• Twin birth rate was 16.3%, 6.7%, and 0 (of all live births) for ages
43, 44, and 45 years, respectively.
• There was no higher order multiple births.
Fertil Steril. 2014 Dec;102(6):1626-32
Beyond the ASRM transfer guidelines:
how many cleavage-stage embryos are safe
to transfer in women ≥43 years old?
• Women aged 43 and 44 years having five or more embryos
transferred experienced higher clinical pregnancy rates (PRs) than
those patients receiving a transfer of three or four embryos.
• Clinical outcomes for patients undergoing transfer with six or more
embryos were not better than those undergoing transfer with five
embryos.
CONCLUSION(S):
• Transferring five or more day 3 embryos may be a safe option for
patients ≥43 years of age, as it is associated with an overall low
rate of multiple gestations.
• Having more than five embryos available for transfer on day 5 is
associated with improved IVF outcomes.
• Whether this benefit is from the additional embryo(s) for transfer or
the inherently better prognosis of such patients remains to be
determined.
Fertil Steril. 2014 Dec;102(6):1626-32
Twins even after SET???
Twins even after SET???
• To compare monozygotic twinning (MZT) rates in patients undergoing
blastocyst or cleavage-stage ET.
• Retrospective cohort.
• Autologous, fresh IVF cycles resulting in a clinical pregnancy
• There were a total of 9,969 fresh transfer cycles resulting in a pregnancy
during the study period.
• Of these pregnancies, 234 monozygotic twin pregnancies were identified
(2.4%).
• Of all transfers, 5,191 were cleavage-stage and 4,778 were blastocyst-stage
transfers.
• There were a total of 99 MZT identified in the cleavage-stage group
(1.9%) and 135 MZT in the blastocyst ET group (2.4%), which
was significant.
• When controlling for patient age, time period during which the cycle took
place, the number and proportion of six- to eight-cell embryos, and
availability of supernumerary embryos, there was no longer a
difference in MZT rate between blastocyst and cleavage transfer.
Fertil Steril. 2015 Jan;103(1):95-100
What makes them split?
Identifying risk factors that lead to
monozygotic twins after IVF
• Of 6,223 gestations, 131 MZTs were diagnosed (2.1%
incidence; 2.0% in autologous and 2.7% in donor IVF cycles),
10 were dichorionic, and 121 were monochorionic.
• Controlling for all risk factors, young oocyte age, extended
culture (noncleavage embryos transferred on/after day 4),
and year of IVF treatment cycle were significantly associated
with MZT.
• day 3 assisted hatching correlated more with
dichorionic MZT, whereas extended culture and
advanced day 5 embryonic stage correlated with
monochorionic MZT.
Fertil Steril. 2014 Jul;102(1):82-9
Incidence and zygosity of twin births
following single fresh or frozen ET
• A total of 4701 patients in a large private IVF unit who
gave birth following SET with a fresh or frozen embryo
with complete follow-up.
• Of 137 viable twins at the 7-week ultrasound, 109 were
delivered as twins
Wider implications of the findings:
• As many as 1 in 5 twins born after SET may be the
result of a concurrent natural conception.
• Couples therefore need to be counselled regarding the
relative benefits and risks of intercourse in assisted
reproduction technology cycles where spontaneous
conception is possible
Hum Reprod. 2014 Jul;29(7):1438-43
Management
• Selective fetal reduction
• Same as that for non ART twins
• Vaginal infection
• Steroids
• Good monitoring
• Multidisciplinary approach
Summary
• Is it different?
• Is it preventable?
• How to prevent?
• Is eSET is solution to
all the problems?
• How to balance ??
ASRM guidelines
Take Home Message
• All efforts should be made to assure a singleton
birth when treating infertility.
• Tight rope walk for IVF consultants
• Risk of multiple pregnancy vs the success
rate/cycle
Reprod Biomed Online. 2014
Multiple pregnancy after art

More Related Content

What's hot

Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018
Lifecare Centre
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
Niranjan Chavan
 
Practical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cyclePractical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cycleLifecare Centre
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
Dr.Laxmi Agrawal Shrikhande
 
Difficult lscs
Difficult lscsDifficult lscs
Difficult lscs
Niranjan Chavan
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
Hesham Gaber
 
Single Embryo Transfer
Single Embryo TransferSingle Embryo Transfer
Single Embryo Transfer
Dr.Laxmi Agrawal Shrikhande
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
Bharati Dhorepatil
 
Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology) Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology)
D.A.B.M
 
Vault prolapse, Pelvic organ Prolapse, Supports Of Uterus
Vault   prolapse, Pelvic organ Prolapse, Supports Of UterusVault   prolapse, Pelvic organ Prolapse, Supports Of Uterus
Vault prolapse, Pelvic organ Prolapse, Supports Of Uterus
Jograjiya Gelabhai Raghubhai
 
Role of IUI in the era of IVF
Role of IUI in the era of IVFRole of IUI in the era of IVF
Role of IUI in the era of IVF
Sujoy Dasgupta
 
OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesSandro Esteves
 
Difficult extraction of the fetus presented in aicog 09.01.19
Difficult extraction of the fetus presented in aicog 09.01.19Difficult extraction of the fetus presented in aicog 09.01.19
Difficult extraction of the fetus presented in aicog 09.01.19
Niranjan Chavan
 
Role of tubal surgery in era of ivf
Role of tubal surgery in era of ivfRole of tubal surgery in era of ivf
Role of tubal surgery in era of ivf
Sanjay Makwana
 
Long Acting Reversible Contraception
Long Acting Reversible ContraceptionLong Acting Reversible Contraception
Long Acting Reversible Contraception
hmhbga
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
Lifecare Centre
 
Iui - newer concepts
Iui  - newer conceptsIui  - newer concepts
Iui - newer concepts
Dr Sachin Dalal
 
Endometriosis in IVF
Endometriosis in IVFEndometriosis in IVF
Endometriosis in IVF
Sujoy Dasgupta
 
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
Pradeep Garg
 

What's hot (20)

Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
 
Practical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cyclePractical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cycle
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
 
Difficult lscs
Difficult lscsDifficult lscs
Difficult lscs
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
 
Single Embryo Transfer
Single Embryo TransferSingle Embryo Transfer
Single Embryo Transfer
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
 
Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology) Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology)
 
Vault prolapse, Pelvic organ Prolapse, Supports Of Uterus
Vault   prolapse, Pelvic organ Prolapse, Supports Of UterusVault   prolapse, Pelvic organ Prolapse, Supports Of Uterus
Vault prolapse, Pelvic organ Prolapse, Supports Of Uterus
 
Role of IUI in the era of IVF
Role of IUI in the era of IVFRole of IUI in the era of IVF
Role of IUI in the era of IVF
 
OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI Cycles
 
Difficult extraction of the fetus presented in aicog 09.01.19
Difficult extraction of the fetus presented in aicog 09.01.19Difficult extraction of the fetus presented in aicog 09.01.19
Difficult extraction of the fetus presented in aicog 09.01.19
 
Role of tubal surgery in era of ivf
Role of tubal surgery in era of ivfRole of tubal surgery in era of ivf
Role of tubal surgery in era of ivf
 
Long Acting Reversible Contraception
Long Acting Reversible ContraceptionLong Acting Reversible Contraception
Long Acting Reversible Contraception
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
 
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
 
Iui - newer concepts
Iui  - newer conceptsIui  - newer concepts
Iui - newer concepts
 
Endometriosis in IVF
Endometriosis in IVFEndometriosis in IVF
Endometriosis in IVF
 
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
 

Similar to Multiple pregnancy after art

Presentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptxPresentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptx
drshivanisachdev1
 
Multiple pregnancy after ART
Multiple pregnancy after ARTMultiple pregnancy after ART
Multiple pregnancy after ART
Dr.Laxmi Agrawal Shrikhande
 
Management of IVF Pregnancy
Management of IVF PregnancyManagement of IVF Pregnancy
Management of IVF Pregnancy
Kaberi Banerjee
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and Harms
Dr. Jyoti Malik
 
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFERCLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
Kaberi Banerjee
 
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamatTwin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
Dr Zharifhussein
 
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in DelhiBest Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
Dr. K.D Nayar IVF Specialist
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
Sujoy Dasgupta
 
Twin pregnancy
Twin pregnancyTwin pregnancy
Twin pregnancy
Poonam Loomba
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
SriSushmaNagasuri
 
Twin pregnancy.pptx
Twin pregnancy.pptxTwin pregnancy.pptx
Twin pregnancy.pptx
ShubhaSiraRavi
 
Elective Single Embryo Transfer- An Insight
Elective Single  Embryo Transfer- An InsightElective Single  Embryo Transfer- An Insight
Elective Single Embryo Transfer- An Insight
Kaberi Banerjee
 
Why Not Era
Why Not EraWhy Not Era
Why Not Era
Kaberi Banerjee
 
Day3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo TransferDay3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo Transfer
Sujoy Dasgupta
 
SAFOG RCOG DAY 6-7-2018
SAFOG RCOG DAY 6-7-2018SAFOG RCOG DAY 6-7-2018
SAFOG RCOG DAY 6-7-2018
NARENDRA C MALHOTRA
 
Austin Journal of Invitro Fertilization
Austin Journal of Invitro FertilizationAustin Journal of Invitro Fertilization
Austin Journal of Invitro Fertilization
Austin Publishing Group
 
Blastocyst transfer
Blastocyst transferBlastocyst transfer
Blastocyst transfer
Antima Rathore
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
NARENDRA C MALHOTRA
 
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsiPrecautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
Lifecare Centre
 

Similar to Multiple pregnancy after art (20)

Presentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptxPresentation on D3 versus D5 Embryo Transfer.pptx
Presentation on D3 versus D5 Embryo Transfer.pptx
 
Multiple pregnancy after ART
Multiple pregnancy after ARTMultiple pregnancy after ART
Multiple pregnancy after ART
 
Management of IVF Pregnancy
Management of IVF PregnancyManagement of IVF Pregnancy
Management of IVF Pregnancy
 
Blastocyst Culture Benefit and Harms
Blastocyst Culture  Benefit and HarmsBlastocyst Culture  Benefit and Harms
Blastocyst Culture Benefit and Harms
 
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFERCLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
CLEAVAGE OR BLASTOCYST EMBRYO TRANSFER
 
Twin pregnancy update hospital segamat
Twin pregnancy update hospital segamatTwin pregnancy update hospital segamat
Twin pregnancy update hospital segamat
 
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in DelhiBest Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
Best Ivf Specialist Doctor Dr. K.D.Nayar Clinic in Delhi
 
Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
 
Twin pregnancy
Twin pregnancyTwin pregnancy
Twin pregnancy
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
 
Twin pregnancy.pptx
Twin pregnancy.pptxTwin pregnancy.pptx
Twin pregnancy.pptx
 
Elective Single Embryo Transfer- An Insight
Elective Single  Embryo Transfer- An InsightElective Single  Embryo Transfer- An Insight
Elective Single Embryo Transfer- An Insight
 
Why Not Era
Why Not EraWhy Not Era
Why Not Era
 
Day3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo TransferDay3 versus Day5 Embryo Transfer
Day3 versus Day5 Embryo Transfer
 
SAFOG RCOG DAY 6-7-2018
SAFOG RCOG DAY 6-7-2018SAFOG RCOG DAY 6-7-2018
SAFOG RCOG DAY 6-7-2018
 
論文
論文論文
論文
 
Austin Journal of Invitro Fertilization
Austin Journal of Invitro FertilizationAustin Journal of Invitro Fertilization
Austin Journal of Invitro Fertilization
 
Blastocyst transfer
Blastocyst transferBlastocyst transfer
Blastocyst transfer
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
 
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsiPrecautions after ivf pregnancy , lifecare centre ,IVF icsi
Precautions after ivf pregnancy , lifecare centre ,IVF icsi
 

More from Dr.Laxmi Agrawal Shrikhande

5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy
Dr.Laxmi Agrawal Shrikhande
 
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and ManagementUnderstanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Dr.Laxmi Agrawal Shrikhande
 
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with AgeUnderstanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Dr.Laxmi Agrawal Shrikhande
 
Urinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptxUrinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptx
Dr.Laxmi Agrawal Shrikhande
 
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Dr.Laxmi Agrawal Shrikhande
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Dr.Laxmi Agrawal Shrikhande
 
Nourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at MidlifeNourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at Midlife
Dr.Laxmi Agrawal Shrikhande
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Dr.Laxmi Agrawal Shrikhande
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
GDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptxGDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptx
Dr.Laxmi Agrawal Shrikhande
 
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
Dr.Laxmi Agrawal Shrikhande
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Dr.Laxmi Agrawal Shrikhande
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
Dr.Laxmi Agrawal Shrikhande
 
Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1
Dr.Laxmi Agrawal Shrikhande
 
Non Specific Musculoskeletal Pain
Non Specific Musculoskeletal PainNon Specific Musculoskeletal Pain
Non Specific Musculoskeletal Pain
Dr.Laxmi Agrawal Shrikhande
 
Preview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal PainPreview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal Pain
Dr.Laxmi Agrawal Shrikhande
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptx
Dr.Laxmi Agrawal Shrikhande
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we going
Dr.Laxmi Agrawal Shrikhande
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
Dr.Laxmi Agrawal Shrikhande
 
Oral health & Pregnancy.pptx
Oral health & Pregnancy.pptxOral health & Pregnancy.pptx
Oral health & Pregnancy.pptx
Dr.Laxmi Agrawal Shrikhande
 

More from Dr.Laxmi Agrawal Shrikhande (20)

5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy5 Essential Steps for Menopause Hormone Therapy
5 Essential Steps for Menopause Hormone Therapy
 
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and ManagementUnderstanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
Understanding Metabolic Syndrome in PCOS: Symptoms, Risks, and Management
 
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with AgeUnderstanding Late Onset Menopause: Navigating Reproductive Changes with Age
Understanding Late Onset Menopause: Navigating Reproductive Changes with Age
 
Urinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptxUrinary Tract Infection in Pregnancy.pptx
Urinary Tract Infection in Pregnancy.pptx
 
Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception Care
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
 
Nourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at MidlifeNourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at Midlife
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
 
GDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptxGDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptx
 
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the lea...
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1
 
Non Specific Musculoskeletal Pain
Non Specific Musculoskeletal PainNon Specific Musculoskeletal Pain
Non Specific Musculoskeletal Pain
 
Preview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal PainPreview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal Pain
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptx
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we going
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
Oral health & Pregnancy.pptx
Oral health & Pregnancy.pptxOral health & Pregnancy.pptx
Oral health & Pregnancy.pptx
 

Recently uploaded

Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
The Lifesciences Magazine
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Dr. David Greene Arizona
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
Kenneth Kruk
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
MiadAlsulami
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
fahmyahmed789
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 

Recently uploaded (20)

Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 

Multiple pregnancy after art

  • 1. Dr. Laxmi Shrikhande MD; FICOG; FICMCH;FICMU  Director-Shrikhande Fertility Clinic, Nagpur  Senior Vice President FOGSI 2012  National Corresponding Editor-Journal of OB/GY of India  Peer Reviewer-The Journal of OB / GY of India  Publications-Eleven National & seven International  Presented Papers at FIGO,SAFOG,AOFOG,AICC RCOG  Editor-FOGSI Focus on SUI  Received Best committee award of FOGSI  Received Bharat Excellence award
  • 2. Multiple pregnancy after ART Dr Laxmi Shrikhande Director-Shrikhande Fertility Clinic, Nagpur, INDIA
  • 3. Why so much concern? • undesirable complication of ovulation induction and/or ovulation enhancement • constitute an important health problem due to high perinatal risks and increased health costs.
  • 4. Is it different from natural multiple gestation?? • retrospective analysis • 106 IVF group and 256 spontaneous twin pregnancies • The mothers in the IVF group were significantly older than those in the control group (32±4 years vs 28±4 years, P<0.05). • The incidence rates of gestational hypertension and gestational diabetes in the IVF group were significantly higher than in the control group (P<0.05). • No significant differences were observed for neonatal physical development, the incidence of birth defects, and the incidence and mortality of perinatal diseases (P>0.05). CONCLUSIONS: • Twins conceived by IVF have similar outcomes as spontaneously conceived twins in the perinatal period. • However, special attention is needed to monitor the levels of blood pressure and blood glucose for pregnant women with twins conceived by IVF during prenatal checkups. Zhongguo Dang Dai Er Ke Za Zhi. 2015
  • 5. Obstetric and perinatal outcomes of twin pregnancies conceived following IVF/ICSI compared with spontaneously conceived twin pregnancies • retrospective study • of all viable dichorionic-diamniotic (DCDA) twin pregnancies (n=539) • The ART conceived group were on average 4 years older (36.8±4.23 vs 32.3±4.93 years) and more frequently nulliparous (73.7%; n=126 vs 36.1%; n=133) than their SC counterparts (p<0.001). • There was no significant difference in maternal antenatal complications. • ART twins were twice as likely to be delivered by caesarean section (CS) (OR 2.35; 95% CI 1.76-3.14). • There was no significant difference in the rates of preterm birth or NICU admission according to mode of conception. • ART conceived twins were almost twice as likely to be delivered moderately preterm (32-33(+6)) (OR 1.98, 95% CI 1.21-3.23) and were more likely to have RDS and neonatal hypoglycaemia CONCLUSIONS: • However, for those that do conceive twins, they can be advised that assisted conception conveys no significant disadvantage over naturally conceived twin pregnancies. Eur J Obstet Gynecol Reprod Biol. 2014
  • 6. Features of multiple pregnancies obtained by in vitro fertilization • A total of 401 spontaneous multiple pregnancies and 128 IVF multiple pregnancies were included in the study. • Rate of multiple pregnancies for live births and IVF rate were 3.8% and 0.79%, respectively. • The mean maternal age was 30.1 years (21-43) in the IVF group and 27.9 years (13-43) in the spontaneous group (P < 0.05). • The cesarean delivery rate was 100% in the IVF group and 78% in the spontaneous group (P = 0.002). • Premature rupture of membranes rate was 9.8% in the IVF group and 3.6% in the spontaneous group (P < 0.05). CONCLUSIONS: • We found maternal age, premature rupture of membranes and cesarean delivery rate significantly high in the IVF group. • No significant differences were found between spontaneous and IVF multiple pregnancies in terms of demographic features, hospitalization stay and rate, admission to neonatal intensive care unit, mortality and congenital malformation. Pediatr Int. 2014 Oct;56(5):735-41
  • 7. Prevention is better than cure!!! • All efforts should be made to assure a singleton birth when treating infertility. • Tight rope walk for IVF consultants • Risk of multiple pregnancy vs the success rate/cycle Reprod Biomed Online. 2014
  • 8. IUI-When to cancel the cycle
  • 9. How many embryos??? • Elective single embryo transfer (eSET) is advocated in most European countries. • In Belgium and Sweden, eSET is mandatory for couples with a good prognosis. • However, despite clinical recommendations and policy statements, patients in clinical practice frequently do request for the transfer of multiple embryos in order to have twins. Ann Med Health Sci Res. 2015 Jan-Feb;5(1)
  • 10. Elective single versus double embryo transfer: live birth outcome and patient acceptance in a prospective randomised trial • 199 women <38 years of age undergoing their first IVF treatment in a private centre were included in a prospective open-label randomised controlled trial. • Of 98 patients selected for eSET, 40% refused and preferred eDET even after having been well informed about its benefits. Reprod Fertil Dev. 2014
  • 11. Number of embryos for transfer following IVF / ICSI • Multiple embryo transfer during IVF increases multiple pregnancy rates causing maternal and perinatal morbidity. • Single embryo transfer is now being seriously considered as a means of minimising the risk of multiple pregnancy. • However, this needs to be balanced against the risk of jeopardising the overall live birth rate. • Fourteen RCTs were included in the review (2165 women). Thirteen compared cleavage-stage transfers (2017 women) and two compared blastocyst transfers (148 women): one study compared both. Cochrane Database Syst Rev. 2013
  • 12. Number of embryos for transfer following IVF / ICSI AUTHORS' CONCLUSIONS: • In a single fresh IVF cycle, single embryo transfer is associated with a lower live birth rate than double embryo transfer. • However, there is no evidence of a significant difference in the cumulative live birth rate when a single cycle of double embryo transfer is compared with repeated SET (either two cycles of fresh SET or one cycle of fresh SET followed by one frozen SET in a natural or hormone-stimulated cycle). • Single embryo transfer is associated with much lower rates of multiple pregnancy than other embryo transfer policies. • A policy of repeated SET may minimise the risk of multiple pregnancy in couples undergoing ART without substantially reducing the likelihood of achieving a live birth. • Most of the evidence currently available concerns younger women with a good prognosis. Cochrane Database Syst Rev. 2013
  • 13. Clinical effectiveness of elective single versus double embryo transfer: meta-analysis from randomised trials • eight eligible trials (n=1367). • A total of 683 and 684 women randomised to the single and double embryo transfer arms, respectively, • The overall live birth rate in a fresh IVF cycle was lower after single (181/683, 27%) than double embryo transfer (285/683, 42%) CONCLUSIONS: • Elective single embryo transfer results in a higher chance of delivering a term singleton live birth compared with double embryo transfer. • Although this strategy yields a lower pregnancy rate than a double embryo transfer in a fresh IVF cycle, this difference is almost completely overcome by an additional frozen single embryo transfer cycle. • The multiple pregnancy rate after elective single embryo transfer is comparable with that observed in spontaneous pregnancies. BMJ. 2010
  • 14. ET practices in the United States • Retrospective cohort analysis • Of 134,381 ART transfer cycles performed in 2012, 51,262 resulted in live births, of which 13,563 (26.5%) were multiple births: 13,123 twin and 440 triplet and higher order births. • Almost half of these multiple births resulted from the following four cycle types: – two fresh blastocyst transfers -less than 35 years , – two fresh blastocyst transfers among donor-oocyte recipients , – two frozen/thawed ETs among patients less than 35 years – More than half of triplet or higher order births resulted from the transfer of two embryos among frozen/thawed autologous transfers). CONCLUSION- • A substantial reduction of ART-related multiple (both twin and triplet or higher order) births in the United States could be achieved by single blastocyst transfers among favorable and average prognosis patients less than 35 years of age and donor-oocyte recipients. Fertil Steril. 2015 Apr;103(4):954-61
  • 15. ASRM guidelines A. Patients under the age of 35 who have a favorable prognosis should be offered a single-embryo transfer and no more than two embryos (cleavage stage or blastocyst) should be transferred . If two embryos are transferred, the patient(s) must be counseled regarding the risks of multifetal pregnancy and the counseling should be documented in the patient's permanent medical record. B. For patients between 35 and 37 years of age who have a favorable prognosis, no more than two cleavage stage embryos should be transferred. All others in this age group should have no more than three cleavage stage embryos transferred. If extended culture is performed, no more than two blastocysts should be transferred to women in this age group. C. For patients between 38 and 40 years of age who have a favorable prognosis, no more than three cleavage stage embryos or two blastocysts should be transferred. All others in this age group should have no more than four cleavage- stage embryos or three blastocysts transferred. D. For patients 41–42 years of age, no more than five cleavage-stage embryos or three blastocyts should be Transferred. Fertil Steril. 2013
  • 16. ASRM guidelines E. In each of the above age groups, for patients with two or more previous failed fresh IVF cycles or a less favorable prognosis, one additional embryo may be transferred according to individual circumstances.The patient must be counseled regarding the risks of multifetal pregnancy. Both the counseling and the justification for exceeding the recommended limits must be documented in the patient(s)'s permanent medical record. F. In women >43 years of age, there are insufficient data to recommend a limit on the number of embryos to transfer. G. In donor-egg cycles, the age of the donor should be used to determine the appropriate number of embryos to transfer, but when the donor is <35 years of age single embryo transfer should be strongly considered. H. In frozen-embryo transfer cycles, the number of good quality thawed embryos transferred should not exceed the recommended limit on the number of fresh embryos transferred for each age group. Fertil Steril. 2013
  • 17. Beyond the ASRM transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? • Retrospective cohort. • A total of 567 cycles in 464 patients aged 43-45 years, whose IVF cycles were characterized by transfer of five to eight cleavage-stage embryos were identified • Live birth rates per transfer were 14.4%, 9.4%, and 1.3% for women aged 43, 44, and 45 years, respectively. In 43-year-old women, 2.9% (2/69) of pregnancies were triplet gestations (one selective reduction and one spontaneous reduction). • Twin birth rate was 16.3%, 6.7%, and 0 (of all live births) for ages 43, 44, and 45 years, respectively. • There was no higher order multiple births. Fertil Steril. 2014 Dec;102(6):1626-32
  • 18. Beyond the ASRM transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? • Women aged 43 and 44 years having five or more embryos transferred experienced higher clinical pregnancy rates (PRs) than those patients receiving a transfer of three or four embryos. • Clinical outcomes for patients undergoing transfer with six or more embryos were not better than those undergoing transfer with five embryos. CONCLUSION(S): • Transferring five or more day 3 embryos may be a safe option for patients ≥43 years of age, as it is associated with an overall low rate of multiple gestations. • Having more than five embryos available for transfer on day 5 is associated with improved IVF outcomes. • Whether this benefit is from the additional embryo(s) for transfer or the inherently better prognosis of such patients remains to be determined. Fertil Steril. 2014 Dec;102(6):1626-32
  • 20. Twins even after SET??? • To compare monozygotic twinning (MZT) rates in patients undergoing blastocyst or cleavage-stage ET. • Retrospective cohort. • Autologous, fresh IVF cycles resulting in a clinical pregnancy • There were a total of 9,969 fresh transfer cycles resulting in a pregnancy during the study period. • Of these pregnancies, 234 monozygotic twin pregnancies were identified (2.4%). • Of all transfers, 5,191 were cleavage-stage and 4,778 were blastocyst-stage transfers. • There were a total of 99 MZT identified in the cleavage-stage group (1.9%) and 135 MZT in the blastocyst ET group (2.4%), which was significant. • When controlling for patient age, time period during which the cycle took place, the number and proportion of six- to eight-cell embryos, and availability of supernumerary embryos, there was no longer a difference in MZT rate between blastocyst and cleavage transfer. Fertil Steril. 2015 Jan;103(1):95-100
  • 21. What makes them split? Identifying risk factors that lead to monozygotic twins after IVF • Of 6,223 gestations, 131 MZTs were diagnosed (2.1% incidence; 2.0% in autologous and 2.7% in donor IVF cycles), 10 were dichorionic, and 121 were monochorionic. • Controlling for all risk factors, young oocyte age, extended culture (noncleavage embryos transferred on/after day 4), and year of IVF treatment cycle were significantly associated with MZT. • day 3 assisted hatching correlated more with dichorionic MZT, whereas extended culture and advanced day 5 embryonic stage correlated with monochorionic MZT. Fertil Steril. 2014 Jul;102(1):82-9
  • 22. Incidence and zygosity of twin births following single fresh or frozen ET • A total of 4701 patients in a large private IVF unit who gave birth following SET with a fresh or frozen embryo with complete follow-up. • Of 137 viable twins at the 7-week ultrasound, 109 were delivered as twins Wider implications of the findings: • As many as 1 in 5 twins born after SET may be the result of a concurrent natural conception. • Couples therefore need to be counselled regarding the relative benefits and risks of intercourse in assisted reproduction technology cycles where spontaneous conception is possible Hum Reprod. 2014 Jul;29(7):1438-43
  • 23. Management • Selective fetal reduction • Same as that for non ART twins • Vaginal infection • Steroids • Good monitoring • Multidisciplinary approach
  • 24. Summary • Is it different? • Is it preventable? • How to prevent? • Is eSET is solution to all the problems? • How to balance ?? ASRM guidelines
  • 25. Take Home Message • All efforts should be made to assure a singleton birth when treating infertility. • Tight rope walk for IVF consultants • Risk of multiple pregnancy vs the success rate/cycle Reprod Biomed Online. 2014

Editor's Notes

  1. A retrospective study of all viable dichorionic-diamniotic (DCDA) twin pregnancies (n=539) delivered at Ireland were divided according to spontaneous conception (SC) and ART conception, specifically IVF or ICSI. The ART conceived group were on average 4 years older (36.8±4.23 vs 32.3±4.93 years) and more frequently nulliparous (73.7%; n=126 vs 36.1%; n=133) than their SC counterparts (p<0.001). There was no significant difference in maternal antenatal complications. ART twins were twice as likely to be delivered by caesarean section (CS) (OR 2.35; 95% CI 1.76-3.14). There was no significant difference in the rates of preterm birth or NICU admission according to mode of conception. ART conceived twins were almost twice as likely to be delivered moderately preterm (32-33(+6)) (OR 1.98, 95% CI 1.21-3.23) and were more likely to have RDS and neonatal hypoglycaemia CONCLUSIONS: Twin pregnancy, irrespective of mode of conception, carries an increased risk of morbidity and mortality for both mother and babies and therefore couples should be counselled regarding the increased risk of iatrogenic twinning associated with double embryo transfer. However, for those that do conceive twins, they can be advised that assisted conception conveys no significant disadvantage over naturally conceived twin pregnancies.
  2. WHAT IS KNOWN ALREADY: The twinning rate after SET is higher than following natural conception. Most studies of twins following SET have incorrectly assumed monozygosity or have not been able to assess the zygosity.